Back to CVE records
Low 3.3HealthcarePublished Feb 18, 2022

CVE-2022-24060This vulnerability allows remote attackers to disclose sensitive information on affected installations of Sante DICOM Viewer Pro 11.8.7.0.

Updated under an hour ago ()

Does this affect you?

It affects Sante DICOM Viewer Pro and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 1.54%, higher than 74% of scored CVEs.

This vulnerability allows remote attackers to disclose sensitive information on affected installations of Sante DICOM Viewer Pro 11.8.7.0. User interaction is required to exploit this vulnerability in that the target must visit a malicious page or open a malicious file. The specific flaw exists within the parsing of DCM files. Crafted data in a DCM file can trigger a read past the end of an allocated buffer. An attacker can leverage this in conjunction with other vulnerabilities to execute arbitrary code in the context of the current process. Was ZDI-CAN-15099.

CVSS
3.3 LOW (v3.0, CNA)CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
Weakness (CWE)
CWE-125
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
1.54% (percentile 74)
Assigned by
zdi
NVD analysis
Modified
Record last updated
Aug 3, 2024
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Sante DICOM Viewer Pro
sante:dicom_viewer_pro (from the name)
11.8.7.0
CNA record
santesoft dicom_viewer_pro
santesoft:dicom_viewer_pro
11.8.7
NVD

References

  • x-refsource-misc, third-party-advisory, vdb-entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.